[内皮素受体拮抗剂在欧洲肺动脉高压新指南中的应用] - Suppr

Suppr

超能文献

[Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].

作者信息

Montani D, Humbert M

出版信息

Rev Mal Respir. 2010 Feb;27(2):103-5. doi: 10.1016/j.rmr.2009.12.007. Epub 2010 Jan 25.

DOI:10.1016/j.rmr.2009.12.007

PMID:20206056

Abstract

摘要

相似文献

[Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].

Rev Mal Respir. 2010 Feb;27(2):103-5. doi: 10.1016/j.rmr.2009.12.007. Epub 2010 Jan 25.

[Specific drugs for the treatment of pulmonary arterial hypertension - current status].

Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S183-6. doi: 10.1055/s-0028-1091234. Epub 2008 Sep 23.

Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan.

Intern Med J. 2012 Dec;42(12):1351-4. doi: 10.1111/imj.12007.

Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.

Br J Haematol. 2009 Dec;147(5):737-43. doi: 10.1111/j.1365-2141.2009.07906.x. Epub 2009 Sep 22.

Oral Therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.

Appl Health Econ Health Policy. 2010;8(1):69-71; author reply 71-3. doi: 10.1007/BF03256167.

[Guidelines for the diagnosis and treatment of pulmonary hypertension].

Rev Mal Respir. 2010 Feb;27(2):141-50. doi: 10.1016/j.rmr.2009.11.013. Epub 2010 Feb 12.

An evidence-based approach to the management of pulmonary arterial hypertension.

Curr Opin Cardiol. 2006 Sep;21(5):526; author reply 526-7. doi: 10.1097/01.hco.0000240592.44957.4b.

Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.

Clin Chest Med. 2007 Mar;28(1):117-25, viii. doi: 10.1016/j.ccm.2006.11.002.

[Treatment of pulmonary arterial hypertension: endothelin-receptor antagonists].

Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S308-10. doi: 10.1055/s-2006-957198.

An evidence-based approach to the management of pulmonary arterial hypertension.

Curr Opin Cardiol. 2006 Jul;21(4):385-92. doi: 10.1097/01.hco.0000231410.07426.9b.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].

Rev Mal Respir. 2010 Feb;27(2):103-5. doi: 10.1016/j.rmr.2009.12.007. Epub 2010 Jan 25.

[Specific drugs for the treatment of pulmonary arterial hypertension - current status].

Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S183-6. doi: 10.1055/s-0028-1091234. Epub 2008 Sep 23.

Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan.

Intern Med J. 2012 Dec;42(12):1351-4. doi: 10.1111/imj.12007.

Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.

Br J Haematol. 2009 Dec;147(5):737-43. doi: 10.1111/j.1365-2141.2009.07906.x. Epub 2009 Sep 22.

Oral Therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.

Appl Health Econ Health Policy. 2010;8(1):69-71; author reply 71-3. doi: 10.1007/BF03256167.

[Guidelines for the diagnosis and treatment of pulmonary hypertension].

Rev Mal Respir. 2010 Feb;27(2):141-50. doi: 10.1016/j.rmr.2009.11.013. Epub 2010 Feb 12.

An evidence-based approach to the management of pulmonary arterial hypertension.

Curr Opin Cardiol. 2006 Sep;21(5):526; author reply 526-7. doi: 10.1097/01.hco.0000240592.44957.4b.

Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.

Clin Chest Med. 2007 Mar;28(1):117-25, viii. doi: 10.1016/j.ccm.2006.11.002.

[Treatment of pulmonary arterial hypertension: endothelin-receptor antagonists].

Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S308-10. doi: 10.1055/s-2006-957198.

An evidence-based approach to the management of pulmonary arterial hypertension.

Curr Opin Cardiol. 2006 Jul;21(4):385-92. doi: 10.1097/01.hco.0000231410.07426.9b.